… be employed in everyday clinical practice [4,… ischemic stroke who were treated with
intravenous thrombolysis (IVT), thus indicating a potential role of RDW as an independent biomarker …

… in ischemic stroke patients remains challenging due to limited predictive properties of existing
models. Blood-based biomarkers … to prognostic factors readily available in clinical practice. …

… Clinical treatment of ischemic stroke An effective treatment approach for ischemic stroke is to
restore blood … Ischemic stroke management is still challenging for physicians, particularly in …

… The current challenges in defining ideal biomarkers for stroke … Ongoing biomarker trials
mainly focus on ischemic stroke. … would optimize biomarkers to be used in the clinical setting at …

… , addressing the abovementioned issues. This justifies the need for … , indicators of ischemic
stroke present primarily in blood … are already used in clinical practice and have a documented …

… ischemia plays an important role in specifying the prevention and treatment of ischemic stroke,
so the blood-based biomarkers in this … associated with their use in clinical practice. Firstly, …

… study observed if any blood biomarker(s) could potentially help differentiate between ischemic
stroke … that the data was yet not robust to suggest its routine clinical use.[ 19 ] Preliminary …

… as for blood or urine and not the cerebrospinal fluid as for latter there is a potential risk of …
-analysis assessing the role of 25 biomarkers for diagnosis of ischemic stroke, the three of …

… challenge for researchers in making the assays into the … challenges, the PFT plays a vital
role in the personalized antiplatelet therapy and the prediction of early occurrence of bleeding …

… To overcome such issues, recent pivotal studies on biomarker dynamics in … Acute ischemic
stroke (AIS) diagnosis relies on clinical … to be applied in the clinical setting. In this regard, we …